Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 22Terminated 4Recruiting 4Withdrawn 2Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Oropharyngeal Neoplasms 1Neuralgia 1Head and Neck Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Gabapentin × Clear all
NCT03747562 2024-09-19

stREnGTH

University Hospital, Ghent

Phase 3 Withdrawn
Head & Neck

Head and Neck Neoplasms, Neuralgia

NCT03423264 2024-07-31

PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

University of Chicago

Phase 2 Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡